These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12181107)

  • 1. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Am J Epidemiol; 2002 Aug; 156(4):363-73. PubMed ID: 12181107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
    J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women.
    Riman T; Dickman PW; Nilsson S; Nordlinder H; Magnusson CM; Persson IR
    Eur J Epidemiol; 2004; 19(11):1011-9. PubMed ID: 15648594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
    Risch HA; Marrett LD; Jain M; Howe GR
    Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for ovarian cancer: a case-control study.
    Booth M; Beral V; Smith P
    Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of ovarian cancer survival: a population-based prospective study in Sweden.
    Yang L; Klint A; Lambe M; Bellocco R; Riman T; Bergfeldt K; Persson I; Weiderpass E
    Int J Cancer; 2008 Aug; 123(3):672-9. PubMed ID: 18498135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK; Riordan DG; Cress RD; Goldsmith DF
    Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
    Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
    Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
    Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
    Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of epithelial ovarian cancer in short-term users of oral contraceptives.
    Gross TP; Schlesselman JJ; Stadel BV; Yu W; Lee NC
    Am J Epidemiol; 1992 Jul; 136(1):46-53. PubMed ID: 1415131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
    Wu ML; Whittemore AS; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Am J Epidemiol; 1988 Dec; 128(6):1216-27. PubMed ID: 3195563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
    Modugno F; Ness RB; Wheeler JE
    Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study.
    Hempling RE; Wong C; Piver MS; Natarajan N; Mettlin CJ
    Obstet Gynecol; 1997 Jun; 89(6):1012-6. PubMed ID: 9170483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies.
    Negri E; Tzonou A; Beral V; Lagiou P; Trichopoulos D; Parazzini F; Franceschi S; Booth M; La Vecchia C
    Int J Cancer; 1999 Mar; 80(6):848-51. PubMed ID: 10074916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
    Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; ; Risch HA; Modugno F
    J Natl Cancer Inst; 2023 May; 115(5):539-551. PubMed ID: 36688720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.